SULT1A2
Basic information
Region (hg38): 16:28591943-28597050
Previous symbols: [ "STP2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SULT1A2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 29 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 29 | 2 | 0 |
Variants in SULT1A2
This is a list of pathogenic ClinVar variants found in the SULT1A2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-28592042-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
16-28592074-G-A | not specified | Uncertain significance (May 03, 2023) | ||
16-28592093-G-A | not specified | Uncertain significance (Jun 28, 2023) | ||
16-28592101-T-C | not specified | Uncertain significance (Dec 06, 2022) | ||
16-28592108-C-T | not specified | Uncertain significance (Oct 14, 2023) | ||
16-28592300-C-G | not specified | Uncertain significance (Mar 28, 2022) | ||
16-28592304-C-T | not specified | Likely benign (Aug 30, 2022) | ||
16-28592307-C-G | not specified | Likely benign (Jun 10, 2024) | ||
16-28592307-C-T | not specified | Uncertain significance (Nov 21, 2022) | ||
16-28592401-G-A | not specified | Uncertain significance (May 26, 2022) | ||
16-28592403-C-T | not specified | Uncertain significance (Sep 03, 2024) | ||
16-28592404-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
16-28592422-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
16-28593253-T-A | not specified | Uncertain significance (Aug 13, 2021) | ||
16-28593254-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
16-28593281-G-C | not specified | Uncertain significance (Jun 10, 2024) | ||
16-28593281-G-T | not specified | Uncertain significance (Mar 07, 2024) | ||
16-28593320-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
16-28593337-C-G | not specified | Uncertain significance (Feb 15, 2023) | ||
16-28593343-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
16-28593344-A-G | not specified | Uncertain significance (May 26, 2023) | ||
16-28593454-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
16-28593492-G-C | not specified | Uncertain significance (May 10, 2022) | ||
16-28593496-A-G | not specified | Likely benign (Oct 20, 2021) | ||
16-28593498-A-G | not specified | Uncertain significance (Sep 26, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SULT1A2 | protein_coding | protein_coding | ENST00000395630 | 7 | 5167 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.68e-12 | 0.0248 | 125005 | 9 | 734 | 125748 | 0.00296 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.846 | 211 | 179 | 1.18 | 0.0000108 | 1932 |
Missense in Polyphen | 71 | 57.033 | 1.2449 | 720 | ||
Synonymous | -0.389 | 74 | 69.9 | 1.06 | 0.00000430 | 551 |
Loss of Function | -0.231 | 17 | 16.0 | 1.06 | 8.71e-7 | 165 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0239 | 0.0238 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0149 | 0.0148 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000325 | 0.000325 |
Middle Eastern | 0.0149 | 0.0148 |
South Asian | 0.00102 | 0.00101 |
Other | 0.00114 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of catecholamines, phenolic drugs and neurotransmitters. Is also responsible for the sulfonation and activation of minoxidil. Mediates the metabolic activation of carcinogenic N-hydroxyarylamines to DNA binding products and could so participate as modulating factor of cancer risk.;
- Pathway
- Chemical carcinogenesis - Homo sapiens (human);Sulfation Biotransformation Reaction;Arylamine metabolism;Metapathway biotransformation Phase I and II;Phase II - Conjugation of compounds;Biological oxidations;Metabolism;Cytosolic sulfonation of small molecules;thyroid hormone metabolism II (via conjugation and/or degradation);serotonin degradation;superpathway of tryptophan utilization;melatonin degradation I;superpathway of melatonin degradation
(Consensus)
Recessive Scores
- pRec
- 0.262
Intolerance Scores
- loftool
- 0.248
- rvis_EVS
- 0.82
- rvis_percentile_EVS
- 87.99
Haploinsufficiency Scores
- pHI
- 0.117
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.400
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.954
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- ethanol catabolic process;catecholamine metabolic process;xenobiotic metabolic process;steroid metabolic process;amine biosynthetic process;phenol-containing compound metabolic process;3'-phosphoadenosine 5'-phosphosulfate metabolic process;sulfation
- Cellular component
- cytosol
- Molecular function
- aryl sulfotransferase activity;protein binding;sulfotransferase activity;flavonol 3-sulfotransferase activity